Chemoinformaics analysis of Butylcyclohexane
| Molecular Weight | 140.27 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 6 |
| Exact Molecular Weight | 140.156 | nRing | 1 |
| Solubility: LogS | -5.341 | nHRing | 0 |
| Solubility: LogP | 5.212 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.0359 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.56 |
| Synth | 1.657 |
| Natural Product Likeliness | 0.315 |
| NR-PPAR-gamma | 0.026 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.415 |
| MDCK | 0.0000151 |
| BBB | 0.734 |
| PPB | 0.968972 |
| VDSS | 2.732 |
| FU | 0.019583 |
| CYP1A2-inh | 0.886 |
| CYP1A2-sub | 0.494 |
| CYP2c19-inh | 0.588 |
| CYP2c19-sub | 0.334 |
| CYP2c9-inh | 0.412 |
| CYP2c9-sub | 0.903 |
| CYP2d6-inh | 0.266 |
| CYP2d6-sub | 0.177 |
| CYP3a4-inh | 0.268 |
| CYP3a4-sub | 0.118 |
| CL | 6.222 |
| T12 | 0.167 |
| hERG | 0.082 |
| Ames | 0.008 |
| ROA | 0.033 |
| SkinSen | 0.89 |
| Carcinogencity | 0.068 |
| EI | 0.987 |
| Respiratory | 0.394 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.914317 |